Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow - CNBC

Moderna on Thursday said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine…